Media Center
Press releases
Alfasigma Reports Record Growth in First-Ever Financial Results; €1.87 billion Revenue Setting the Stage for Future Growth
ALFASIGMA AT UEG WEEK (Vienna, 12 -15 OCTOBER 2024)
Alfasigma announces the Completion of Marketing Authorisation Transfer for Jyseleca® in the European Union
Alfasigma completes transaction to acquire the Jyseleca® business from Galapagos for up to €170 million
Alfasigma signs an agreement to acquire Jyseleca® business for up to €170 million from Galapagos following October letter of intent
Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.
Press kit
- Sermoneta plant
- Alanno plant
- Pomezia plant
- Trezzano Plant
- Image library
Press contacts
Corporate Communication & Institutional Relations
Staff
[email protected] +39.051.6489.511Press Office
[email protected]